Substance / Medication

Dicloxacillin

Overview

Active Ingredient
dicloxacillin
RxNorm CUI
3356

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

2 trials linked to this intervention

2
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Advancements in Managing Wound Biofilm: A Systematic Review and Meta-analysis of Randomized Controlled Trials on Topical Modalities.
Astrada Adam, Pamungkas Rian Adi, Abidin Khoirul Rista · Foot Ankle Spec · 2026
PMID: 38282327Meta-Analysis
Phage Therapy in Bacterial Pneumonia Models: A Systematic Review and Meta-Analysis.
Rahman Mohammad Akhlaquer, Verma Kapil Kumar, Posa Mahesh Kumar · Comb Chem High Throughput Screen · 2025
PMID: 38357944Meta-Analysis
Misdiagnosis of Uncomplicated Cellulitis: a Systematic Review and Meta-analysis.
Nightingale Rachael, Yadav Krishan, Hamill Laura et al. · J Gen Intern Med · 2023
PMID: 37231210Meta-AnalysisFull text (PMC)
Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.
Stage Tore Bjerregaard, Graff Magnus, Wong Susan et al. · Br J Clin Pharmacol · 2018
PMID: 29105855RCTFull text (PMC)
Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
Wu Guolan, Zheng Yunliang, Zhou Huili et al. · Drug Des Devel Ther · 2015
PMID: 26527863RCTFull text (PMC)
Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
Beringer Paul M, Kriengkauykiat Jane, Zhang Xiyun et al. · Pharmacotherapy · 2008
PMID: 18576903RCT
Microdialysis as a tool to determine the local tissue concentration of dicloxacillin in man.
Hansen Kristian Kraft, Nielsen Flemming, Stage Tore Bjerregaard et al. · Br J Clin Pharmacol · 2018
PMID: 29105799TrialFull text (PMC)
Cefuroxime vs a dicloxacillin/chloramphenicol combination for the treatment of parapneumonic pleural effusion and empyema in children.
Palacios G C, Gonzalez S N, Perez F L et al. · Pulm Pharmacol Ther · 2002
PMID: 11969360Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dicloxacillin (substance)
SNOMED CT
372873001
UMLS CUI
C0012093
RxNorm CUI
3356

Clinical Data

This intervention maps to 9 entities in the Ltrl knowledge graph.

9
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.